Charles Bennett to Multicenter Studies as Topic
This is a "connection" page, showing publications Charles Bennett has written about Multicenter Studies as Topic.
Connection Strength
0.353
-
Economic analyses of phase III cooperative cancer group clinical trials: are they feasible? Cancer Invest. 1997; 15(3):227-36.
Score: 0.129
-
Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project. Semin Thromb Hemost. 2007 Jun; 33(4):365-72.
Score: 0.066
-
Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review. Best Pract Res Clin Haematol. 2005; 18(3):449-54.
Score: 0.056
-
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr. 2001 Apr 01; 26(4):390-1.
Score: 0.043
-
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer. 1996 May 01; 77(9):1854-61.
Score: 0.031
-
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer. Urology. 2010 Mar; 75(3):623-9.
Score: 0.019
-
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med. 1996 Oct; 11(10):591-6.
Score: 0.008